🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
03/11/2022 0,4000 USD
28/07/2022 0,4000 USD
12/05/2022 0,4000 USD
27/01/2022 0,4000 USD
04/11/2021 0,3900 USD
29/07/2021 0,3900 USD
06/05/2021 0,3900 USD
28/01/2021 0,3900 USD
05/11/2020 0,3605 USD
30/07/2020 0,3605 USD
07/05/2020 0,3605 USD
30/01/2020 0,3605 USD
07/11/2019 0,3416 USD
01/08/2019 0,3416 USD
09/05/2019 0,3416 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/02/2023 42,81 42,93 42,62 42,70 -1,18% 0,72% 17.356.600
17/02/2023 42,89 43,37 42,58 43,21 +0,61% 1,84% 18.293.400
16/02/2023 43,15 43,18 42,77 42,95 -0,85% 0,95% 17.832.000
15/02/2023 43,42 43,61 43,11 43,32 -0,91% 1,15% 18.994.700
14/02/2023 44,09 44,20 43,58 43,72 -0,61% 1,41% 17.506.900
13/02/2023 43,68 44,01 43,51 43,99 +0,25% 1,14% 17.878.000
10/02/2023 43,50 43,98 43,26 43,88 +1,25% 1,66% 18.619.600
09/02/2023 44,12 44,33 43,24 43,34 -1,46% 2,47% 20.809.200
08/02/2023 43,55 44,10 43,53 43,98 +0,89% 1,31% 19.362.300
07/02/2023 43,82 43,90 43,25 43,59 -0,39% 1,48% 22.999.500
06/02/2023 44,19 44,30 43,73 43,76 -0,68% 1,29% 18.071.200
03/02/2023 44,36 44,39 43,88 44,06 -0,63% 1,15% 23.742.000
02/02/2023 43,63 44,46 43,50 44,34 +0,84% 2,20% 35.279.200
01/02/2023 43,91 44,18 43,41 43,97 -0,43% 1,75% 24.482.300
31/01/2023 43,00 44,28 42,70 44,16 +1,40% 3,67% 49.722.500
30/01/2023 43,79 44,14 43,40 43,55 -0,55% 1,69% 24.402.200
27/01/2023 44,22 44,34 43,78 43,79 -1,04% 1,27% 23.798.600
26/01/2023 44,20 44,30 43,61 44,25 -1,82% 1,56% 38.465.500
25/01/2023 45,03 45,11 44,59 45,07 +0,81% 1,15% 20.828.000
24/01/2023 44,92 44,95 44,15 44,71 -0,60% 1,78% 18.853.100
23/01/2023 45,04 45,32 44,82 44,98 -0,29% 1,11% 19.398.600
20/01/2023 45,28 45,43 44,73 45,11 +0,33% 1,55% 25.197.600
19/01/2023 44,72 45,27 44,64 44,96 -0,09% 1,41% 26.614.900
18/01/2023 45,55 45,85 44,97 45,00 -2,34% 1,93% 33.835.000
17/01/2023 46,54 46,74 45,71 46,08 -3,70% 2,21% 29.391.400
13/01/2023 47,50 48,16 47,49 47,85 +0,29% 1,41% 18.737.500
12/01/2023 47,27 47,72 46,58 47,71 +0,55% 2,41% 23.345.300
11/01/2023 47,70 47,74 46,86 47,45 -0,36% 1,84% 23.022.200
10/01/2023 48,35 48,47 47,38 47,62 -1,59% 2,25% 29.212.000
09/01/2023 50,05 50,26 48,31 48,39 -4,97% 3,90% 30.839.100